{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T21:10:15Z","timestamp":1756156215983,"version":"3.44.0"},"reference-count":122,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T00:00:00Z","timestamp":1749859200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009945","name":"Merck KGaA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009945","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Merck Serono SPA"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.critrevonc.2025.104778","type":"journal-article","created":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T12:02:21Z","timestamp":1749816141000},"page":"104778","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Management of ovarian reserve in breast cancer patients seeking pregnancies (MORE BREAKS): A Delphi consensus"],"prefix":"10.1016","volume":"213","author":[{"given":"Carlo","family":"Alviggi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Gabriele Iorio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigi","family":"Carbone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberta","family":"Vallone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fedro Alessandro","family":"Peccatori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Anserini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filippo Maria","family":"Ubaldi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vito","family":"Trojano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola","family":"Colacurci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5676-0055","authenticated-orcid":false,"given":"Alessandro","family":"Conforti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2025.104778_bib1","first-page":"43","article-title":"American cancer Society\/American society of clinical oncology breast cancer survivorship care guideline","volume":"66","author":"Runowicz","year":"2016","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.critrevonc.2025.104778_bib2","doi-asserted-by":"crossref","first-page":"43","DOI":"10.15585\/mmwr.mm7102a2","article-title":"Trends in breast cancer incidence, by race, ethnicity, and age among women aged \u226520 years - United States, 1999-2018","volume":"71","author":"Ellington","year":"2022","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"key":"10.1016\/j.critrevonc.2025.104778_bib3","unstructured":"N. Howlader, A. Noone, M. Krapcho, J. Garshell, SEER cancer statistics review, 1975-2012, (2014). \u3008http:\/\/seer.cancer.gov\/archive\/csr\/1975_2012\/\u3009."},{"key":"10.1016\/j.critrevonc.2025.104778_bib4","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.pop.2009.08.001","article-title":"Survivorship: adult cancer survivors","volume":"36","author":"Ganz","year":"2009","journal-title":"Prim. Care"},{"key":"10.1016\/j.critrevonc.2025.104778_bib5","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJMoa1404037","article-title":"Adjuvant exemestane with ovarian suppression in premenopausal breast cancer","volume":"371","author":"Pagani","year":"2014","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.critrevonc.2025.104778_bib6","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1056\/NEJMoa1803164","article-title":"Tailoring adjuvant endocrine therapy for premenopausal breast cancer","volume":"379","author":"Francis","year":"2018","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.critrevonc.2025.104778_bib7","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1111\/tbj.13474","article-title":"Unexpected ovarian activity in premenopausal breast cancer survivors treated with exemestane and GnRH analogues","volume":"25","author":"Conforti","year":"2019","journal-title":"Breast J."},{"key":"10.1016\/j.critrevonc.2025.104778_bib8","doi-asserted-by":"crossref","DOI":"10.1093\/hropen\/hoaa052","article-title":"ESHRE guideline: female fertility preservation","volume":"2020","author":"ESHRE Guideline Group on Female Fertility Preservation","year":"2020","journal-title":"Hum. Reprod. Open"},{"key":"10.1016\/j.critrevonc.2025.104778_bib9","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1016\/j.annonc.2020.09.006","article-title":"ESMO guidelines committee. Electronic address: clinicalguidelines@esmo.org, fertility preservation and post-treatment pregnancies in post-pubertal cancer patients: ESMO clinical practice Guidelines\u2020","volume":"31","author":"Lambertini","year":"2020","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.critrevonc.2025.104778_bib10","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.breast.2021.07.021","article-title":"Who are the women who enrolled in the POSITIVE trial: a global study to support young hormone receptor positive breast cancer survivors desiring pregnancy","volume":"59","author":"Partridge","year":"2021","journal-title":"Breast"},{"key":"10.1016\/j.critrevonc.2025.104778_bib11","doi-asserted-by":"crossref","unstructured":"A.H. Partridge, S.M. Niman, M. Ruggeri, F.A. Peccatori, H.A. Azim, M. Colleoni, C. Saura, C. Shimizu, A.B. S\u00e6tersdal, J.R. Kroep, A. Mailliez, E. Warner, V.F. Borges, F. Amant, A. Gombos, A. Kataoka, C. Rousset-Jablonski, S. Borstnar, J. Takei, J.E. Lee, J.M. Walshe, M. Ru\u00edz-Borrego, H.C.F. Moore, C. Saunders, V. Bjelic-Radisic, S. Susnjar, F. Cardoso, K.L. Smith, T. Ferreiro, K. Ribi, K. Ruddy, R. Kammler, S. El-Abed, G. Viale, M. Piccart, L.A. Korde, A. Goldhirsch, R.D. Gelber, O. PaganiInternational Breast Cancer Study Group, POSITIVE Trial Collaborators, Interrupting Endocrine Therapy to Attempt Pregnancy after Breast Cancer, N Engl J Med 388 (2023) 1645\u20131656. https:\/\/doi.org\/10.1056\/NEJMoa2212856.","DOI":"10.1056\/NEJMoa2212856"},{"key":"10.1016\/j.critrevonc.2025.104778_bib12","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1046\/j.1365-2648.2000.t01-1-01567.x","article-title":"Research guidelines for the delphi survey technique","volume":"32","author":"Hasson","year":"2000","journal-title":"J. Adv. Nurs."},{"key":"10.1016\/j.critrevonc.2025.104778_bib13","article-title":"Effect of genetic variants of gonadotropins and their receptors on ovarian stimulation outcomes: a delphi consensus","volume":"12","author":"Conforti","year":"2021","journal-title":"Front Endocrinol. (Lausanne)"},{"key":"10.1016\/j.critrevonc.2025.104778_bib14","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1177\/1355819614561537","article-title":"Development of key indicators of hospital resilience: a modified delphi study","volume":"20","author":"Zhong","year":"2015","journal-title":"J. Health Serv. Res Policy"},{"key":"10.1016\/j.critrevonc.2025.104778_bib15","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1007\/s10815-023-02757-4","article-title":"The HERA (Hyper-response Risk Assessment) delphi consensus definition of hyper-responders for in-vitro fertilization","volume":"40","author":"Feferkorn","year":"2023","journal-title":"J. Assist Reprod. Genet"},{"key":"10.1016\/j.critrevonc.2025.104778_bib16","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1477-7827-12-26","article-title":"Serum AMH level as a marker of acute and long-term effects of chemotherapy on the ovarian follicular content: a systematic review","volume":"12","author":"Peign\u00e9","year":"2014","journal-title":"Reprod. Biol. Endocrinol."},{"key":"10.1016\/j.critrevonc.2025.104778_bib17","doi-asserted-by":"crossref","first-page":"3404","DOI":"10.1016\/j.ejca.2013.07.014","article-title":"Pretreatment anti-M\u00fcllerian hormone predicts for loss of ovarian function after chemotherapy for early breast cancer","volume":"49","author":"Anderson","year":"2013","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.critrevonc.2025.104778_bib18","doi-asserted-by":"crossref","first-page":"3691","DOI":"10.1002\/cncr.28942","article-title":"Prechemotherapy antimullerian hormone, age, and body size predict timing of return of ovarian function in young breast cancer patients","volume":"120","author":"Su","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2025.104778_bib19","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1634\/theoncologist.2015-0183","article-title":"Predicting ovarian activity in women affected by early breast cancer: a Meta-Analysis-Based nomogram","volume":"20","author":"Barnabei","year":"2015","journal-title":"Oncologist"},{"key":"10.1016\/j.critrevonc.2025.104778_bib20","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.fertnstert.2009.02.043","article-title":"Dynamics and mechanisms of chemotherapy-induced ovarian follicular depletion in women of fertile age","volume":"94","author":"Rosendahl","year":"2010","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.critrevonc.2025.104778_bib21","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ejca.2017.03.035","article-title":"Prospective evaluation of serum anti-M\u00fcllerian hormone dynamics in 250 women of reproductive age treated with chemotherapy for breast cancer","volume":"79","author":"Dezellus","year":"2017","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.critrevonc.2025.104778_bib22","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.fertnstert.2012.09.039","article-title":"Pretreatment antim\u00fcllerian hormone levels determine rate of posttherapy ovarian reserve recovery: acute changes in ovarian reserve during and after chemotherapy","volume":"99","author":"Dillon","year":"2013","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.critrevonc.2025.104778_bib23","doi-asserted-by":"crossref","first-page":"241","DOI":"10.5306\/wjco.v8.i3.241","article-title":"Current state and controversies in fertility preservation in women with breast cancer","volume":"8","author":"Taylan","year":"2017","journal-title":"World J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2025.104778_bib24","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/978-3-642-68511-8_38","article-title":"The anti-implantation action of tamoxifen in mice","volume":"5","author":"Pugh","year":"1982","journal-title":"Arch. Toxicol. Suppl."},{"key":"10.1016\/j.critrevonc.2025.104778_bib25","first-page":"305","article-title":"Maternal exposure to tamoxifen during pregnancy increases carcinogen-induced mammary tumorigenesis among female rat offspring","volume":"6","author":"Halakivi-Clarke","year":"2000","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.critrevonc.2025.104778_bib26","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1124\/jpet.105.100511","article-title":"Endoxifen, a secondary metabolite of tamoxifen, and 4-OH-tamoxifen induce similar changes in global gene expression patterns in MCF-7 breast cancer cells","volume":"318","author":"Lim","year":"2006","journal-title":"J. Pharm. Exp. Ther."},{"key":"10.1016\/j.critrevonc.2025.104778_bib27","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/S0046-8177(87)80381-7","article-title":"Teratogenic effects of clomiphene, tamoxifen, and diethylstilbestrol on the developing human female genital tract","volume":"18","author":"Cunha","year":"1987","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.critrevonc.2025.104778_bib28","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.mrgentox.2010.08.016","article-title":"Chromosomal aberration in the post-implantation embryos sired by tamoxifen treated Male rats","volume":"703","author":"Kedia-Mokashi","year":"2010","journal-title":"Mutat. Res"},{"key":"10.1016\/j.critrevonc.2025.104778_bib29","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0936-6555(89)80004-4","article-title":"Breast cancer and pregnancy: the ultimate challenge","volume":"1","author":"Clark","year":"1989","journal-title":"Clin. Oncol. (R. Coll. Radio. )"},{"key":"10.1016\/j.critrevonc.2025.104778_bib30","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0890-6238(97)00065-8","article-title":"Initial uterine alterations caused by developmental exposure to tamoxifen","volume":"11","author":"Poulet","year":"1997","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.critrevonc.2025.104778_bib31","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1634\/theoncologist.2011-0121","article-title":"Use of tamoxifen before and during pregnancy","volume":"16","author":"Braems","year":"2011","journal-title":"Oncologist"},{"key":"10.1016\/j.critrevonc.2025.104778_bib32","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.breast.2004.08.007","article-title":"Tamoxifen and pregnancy","volume":"13","author":"Barthelmes","year":"2004","journal-title":"Breast"},{"key":"10.1016\/j.critrevonc.2025.104778_bib33","first-page":"89","article-title":"Serum concentrations of tamoxifen and major metabolite during long-term nolvadex therapy, correlated with clinical response","author":"Patterson","year":"1980","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.critrevonc.2025.104778_bib34","first-page":"1629","article-title":"Concentrations of tamoxifen and its major metabolites in hormone responsive and resistant breast tumours","volume":"82","author":"MacCallum","year":"2000","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.critrevonc.2025.104778_bib35","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/j.fertnstert.2005.03.013","article-title":"Fertility preservation and reproduction in cancer patients","volume":"83","year":"2005","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.critrevonc.2025.104778_bib36","doi-asserted-by":"crossref","unstructured":"Buonomo, B., Azim, H.A., Alviggi, C., Peccatori, F.A., 2019. Epidemiology and General Considerations of Pregnancy Following Cancer Diagnosis, in: Fertility Challenges and Solutions in Women with Cancer, 2019: pp. 3\u20137. https:\/\/doi.org\/10.1007\/978-3-030-24086-8_1..","DOI":"10.1007\/978-3-030-24086-8_1"},{"key":"10.1016\/j.critrevonc.2025.104778_bib37","article-title":"Effects and safety of periconceptional oral folate supplementation for preventing birth defects","volume":"2015","author":"De-Regil","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.critrevonc.2025.104778_bib38","doi-asserted-by":"crossref","first-page":"e62","DOI":"10.1111\/1471-0528.15386","article-title":"Royal college of obstetricians and gynaecologists, care of women with obesity in pregnancy: Green-top guideline no. 72","volume":"126","author":"Denison","year":"2019","journal-title":"BJOG"},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104778_bib39","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s11606-009-1023-8","article-title":"Contraception for cancer survivors","volume":"24","author":"Schwarz","year":"2009","journal-title":"J. Gen. Intern Med"},{"key":"10.1016\/j.critrevonc.2025.104778_bib40","unstructured":"World Health Organization, Medical eligibility criteria for contraceptive use, (2015). \u3008https:\/\/www.who.int\/publications\/i\/item\/9789241549158\u3009 (accessed August 20, 2024)."},{"key":"10.1016\/j.critrevonc.2025.104778_bib41","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/nrc3518","article-title":"Progesterone signalling in breast cancer: a neglected hormone coming into the limelight","volume":"13","author":"Brisken","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.critrevonc.2025.104778_bib42","article-title":"High progesterone levels during the luteal phase related to the use of an aromatase inhibitor in breast cancer patients","volume":"21","author":"Alviggi","year":"2017","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.critrevonc.2025.104778_bib43","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.3645","article-title":"Association of circulating progesterone with breast cancer risk among postmenopausal women","volume":"3","author":"Trabert","year":"2020","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.critrevonc.2025.104778_bib44","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1007\/s11764-019-00765-x","article-title":"Contraceptive utilization and counseling among breast cancer survivors","volume":"13","author":"Mody","year":"2019","journal-title":"J. Cancer Surviv"},{"key":"10.1016\/j.critrevonc.2025.104778_bib45","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.contraception.2010.11.009","article-title":"Levonorgestrel-releasing and copper intrauterine devices and the risk of breast cancer","volume":"83","author":"Dinger","year":"2011","journal-title":"Contraception"},{"key":"10.1016\/j.critrevonc.2025.104778_bib46","doi-asserted-by":"crossref","first-page":"e377","DOI":"10.1097\/AOG.0000000000003271","article-title":"ACOG committee opinion, number 781","volume":"133","author":"Infertility Workup for the Women\u2019s Health Specialist","year":"2019","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.critrevonc.2025.104778_bib47","unstructured":"ASRM, American Society For Reproductive Medicine (Asrm) Patient Management And Clinical Recommendationsduring The Coronavirus (Covid-19) Pandemic Available from: \u3008https:\/\/www.asrm.org\/news-and-publications\/covid-19\/statements\/patient-management-and-clinical-recommendations-during-the-coronavirus-covid-19-pandemic\/\u3009, (2020)."},{"key":"10.1016\/j.critrevonc.2025.104778_bib48","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.fertnstert.2013.12.032","article-title":"Female age-related fertility decline","volume":"101","author":"American College of Obstetricians and Gynecologists Committee on Gynecologic Practice and Practice Committee","year":"2014","journal-title":"Comm. Opin. No. 589 Fertil. Steril."},{"key":"10.1016\/j.critrevonc.2025.104778_bib49","doi-asserted-by":"crossref","first-page":"S163","DOI":"10.1016\/j.fertnstert.2013.07.1488","article-title":"Can AMH be used as a marker of ovarian reserve in young breast cancer patients taking tamoxifen?","volume":"100","author":"Chung","year":"2013","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.critrevonc.2025.104778_bib50","doi-asserted-by":"crossref","first-page":"355","DOI":"10.6004\/jnccn.2016.0038","article-title":"Fertility preservation in patients with breast cancer: necessity, methods, and safety","volume":"14","author":"Waks","year":"2016","journal-title":"J. Natl. Compr. Canc Netw."},{"key":"10.1016\/j.critrevonc.2025.104778_bib51","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.fertnstert.2013.11.004","article-title":"The nature of aneuploidy with increasing age of the female partner: a review of 15,169 consecutive trophectoderm biopsies evaluated with comprehensive chromosomal screening","volume":"101","author":"Franasiak","year":"2014","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.critrevonc.2025.104778_bib52","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.rbmo.2012.02.009","article-title":"Array CGH analysis shows that aneuploidy is not related to the number of embryos generated","volume":"24","author":"Ata","year":"2012","journal-title":"Reprod. Biomed. Online"},{"key":"10.1016\/j.critrevonc.2025.104778_bib53","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1093\/humrep\/dez181","article-title":"Oocyte quantity, as well as oocyte quality, plays a significant role for the cumulative live birth rate of a POSEIDON criteria patient","volume":"34","author":"Esteves","year":"2019","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.critrevonc.2025.104778_bib54","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1093\/humrep\/deab152","article-title":"Cumulative delivery rate per aspiration IVF\/ICSI cycle in POSEIDON patients: a real-world evidence study of 9073 patients","volume":"36","author":"Esteves","year":"2021","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.critrevonc.2025.104778_bib55","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.fertnstert.2023.05.007","article-title":"Bologna vs. Poseidon criteria as predictors of the likelihood of obtaining at least one euploid embryo in poor ovarian response: an analysis of 6,889 cycles","volume":"120","author":"Reig","year":"2023","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.critrevonc.2025.104778_bib56","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.bpobgyn.2022.05.003","article-title":"POSEIDON groups and their distinct reproductive outcomes: effectiveness and cost-effectiveness insights from real-world data research","volume":"85","author":"Esteves","year":"2022","journal-title":"Best. Pr. Res Clin. Obstet. Gynaecol."},{"key":"10.1016\/j.critrevonc.2025.104778_bib57","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s10815-012-9754-6","article-title":"Serum anti-m\u00fcllerian hormone, follicle stimulating hormone and antral follicle count measurement cannot predict pregnancy rates in IVF\/ICSI cycles","volume":"29","author":"Sahmay","year":"2012","journal-title":"J. Assist Reprod. Genet"},{"key":"10.1016\/j.critrevonc.2025.104778_bib58","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.rbmo.2018.01.013","article-title":"Investigation of anti-M\u00fcllerian hormone concentrations in relation to natural conception rate and time to pregnancy","volume":"36","author":"Korsholm","year":"2018","journal-title":"Reprod. Biomed. Online"},{"key":"10.1016\/j.critrevonc.2025.104778_bib59","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.fertnstert.2018.01.039","article-title":"Antim\u00fcllerian hormone as a risk factor for miscarriage in naturally conceived pregnancies","volume":"109","author":"Lyttle Schumacher","year":"2018","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.critrevonc.2025.104778_bib60","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/1477-7827-7-101","article-title":"Biological versus chronological ovarian age: implications for assisted reproductive technology","volume":"7","author":"Alviggi","year":"2009","journal-title":"Reprod. Biol. Endocrinol."},{"key":"10.1016\/j.critrevonc.2025.104778_bib61","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/s41379-020-00650-4","article-title":"Validation of the revised 8th AJCC breast cancer clinical prognostic staging system: analysis of 5321 cases from a single institution","volume":"34","author":"Aldrees","year":"2021","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.critrevonc.2025.104778_bib62","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/818912","article-title":"Potential mechanisms for racial and ethnic differences in antim\u00fcllerian hormone and ovarian reserve","volume":"2013","author":"Tal","year":"2013","journal-title":"Int J. Endocrinol."},{"key":"10.1016\/j.critrevonc.2025.104778_bib63","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ajog.2017.02.027","article-title":"Ovarian reserve testing: a user\u2019s guide","volume":"217","author":"Tal","year":"2017","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.critrevonc.2025.104778_bib64","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1210\/jc.2010-2776","article-title":"Anti-mullerian hormone predicts menopause: a long-term follow-up study in normoovulatory women","volume":"96","author":"Broer","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.critrevonc.2025.104778_bib65","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.fertnstert.2012.07.1139","article-title":"Contribution of the rate of change of antim\u00fcllerian hormone in estimating time to menopause for late reproductive-age women","volume":"98","author":"Freeman","year":"2012","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.critrevonc.2025.104778_bib66","doi-asserted-by":"crossref","DOI":"10.1210\/jc.2011-3032","article-title":"Anti-mullerian hormone as a predictor of time to menopause in late reproductive age women","volume":"97","author":"Freeman","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.critrevonc.2025.104778_bib67","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1093\/humrep\/dew112","article-title":"Does anti-M\u00fcllerian hormone predict menopause in the general population? Results of a prospective ongoing cohort study","volume":"31","author":"Depmann","year":"2016","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.critrevonc.2025.104778_bib68","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1093\/humrep\/dev145","article-title":"Added value of anti-M\u00fcllerian hormone in prediction of menopause: results from a large prospective cohort study","volume":"30","author":"D\u00f3lleman","year":"2015","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.critrevonc.2025.104778_bib69","doi-asserted-by":"crossref","first-page":"777","DOI":"10.3109\/13697137.2015.1036853","article-title":"The utility of measuring anti-M\u00fcllerian hormone in predicting menopause","volume":"18","author":"Aydogan","year":"2015","journal-title":"Climacteric"},{"key":"10.1016\/j.critrevonc.2025.104778_bib70","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1093\/humupd\/dmac045","article-title":"Anti-M\u00fcllerian hormone for the diagnosis and prediction of menopause: a systematic review","volume":"29","author":"Nelson","year":"2023","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.critrevonc.2025.104778_bib71","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.733731","article-title":"Role of AMH in prediction of menopause","volume":"12","author":"de Kat","year":"2021","journal-title":"Front Endocrinol. (Lausanne)"},{"key":"10.1016\/j.critrevonc.2025.104778_bib72","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/j.fertnstert.2013.03.014","article-title":"Antim\u00fcllerian hormone, the assessment of the ovarian reserve, and the reproductive outcome of the young patient with cancer","volume":"99","author":"Anderson","year":"2013","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.critrevonc.2025.104778_bib73","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.fertnstert.2009.04.040","article-title":"The antral follicle count: practical recommendations for better standardization","volume":"94","author":"Broekmans","year":"2010","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.critrevonc.2025.104778_bib74","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.rbmo.2015.06.015","article-title":"Assessing ovarian response: antral follicle count versus anti-M\u00fcllerian hormone","volume":"31","author":"Fleming","year":"2015","journal-title":"Reprod. Biomed. Online"},{"key":"10.1016\/j.critrevonc.2025.104778_bib75","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.fertnstert.2007.12.013","article-title":"The role of antimullerian hormone in prediction of outcome after IVF: comparison with the antral follicle count","volume":"91","author":"Broer","year":"2009","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.critrevonc.2025.104778_bib76","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1093\/humupd\/dml034","article-title":"A systematic review of tests predicting ovarian reserve and IVF outcome","volume":"12","author":"Broekmans","year":"2006","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.critrevonc.2025.104778_bib77","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/S0015-0282(16)54249-6","article-title":"Basal follicle-stimulating hormone level is a better predictor of in vitro fertilization performance than age","volume":"55","author":"Toner","year":"1991","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.critrevonc.2025.104778_bib78","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0015-0282(16)60615-5","article-title":"Follicle-stimulating hormone levels on cycle day 3 are predictive of in vitro fertilization outcome","volume":"51","author":"Scott","year":"1989","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.critrevonc.2025.104778_bib79","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S0015-0282(16)60077-8","article-title":"The value of basal and\/or stimulated serum gonadotropin levels in prediction of stimulation response and in vitro fertilization outcome","volume":"50","author":"Muasher","year":"1988","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.critrevonc.2025.104778_bib80","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0015-0282(16)53707-8","article-title":"Intercycle variability of day 3 follicle-stimulating hormone levels and its effect on stimulation quality in in vitro fertilization","volume":"54","author":"Scott","year":"1990","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.critrevonc.2025.104778_bib81","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1093\/humrep\/deh119","article-title":"Intercycle variability of ovarian reserve tests: results of a prospective randomized study","volume":"19","author":"Kwee","year":"2004","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.critrevonc.2025.104778_bib82","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.fertnstert.2004.06.062","article-title":"Taking a basal follicle-stimulating hormone history is essential before initiating in vitro fertilization","volume":"83","author":"Roberts","year":"2005","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.critrevonc.2025.104778_bib83","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1016\/j.fertnstert.2016.02.001","article-title":"Evidence-based approach to unexplained infertility: a systematic review","volume":"105","author":"Gunn","year":"2016","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.critrevonc.2025.104778_bib84","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/jog.13818","article-title":"Recent advances in fertility preservation","volume":"45","author":"Dolmans","year":"2019","journal-title":"J. Obstet. Gynaecol. Res"},{"key":"10.1016\/j.critrevonc.2025.104778_bib85","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.rbmo.2019.05.023","article-title":"The management of unexplained infertility: an evidence-based guideline from the Canadian fertility and andrology society","volume":"39","author":"Buckett","year":"2019","journal-title":"Reprod. Biomed. Online"},{"key":"10.1016\/j.critrevonc.2025.104778_bib86","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1136\/bmj.291.6510.1693","article-title":"Population study of causes, treatment, and outcome of infertility","volume":"291","author":"Hull","year":"1985","journal-title":"Br. Med J. (Clin. Res Ed."},{"key":"10.1016\/j.critrevonc.2025.104778_bib87","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.rbmo.2020.08.003","article-title":"Cumulative live birth rate of low prognosis patients with POSEIDON stratification: a single-centre data analysis","volume":"41","author":"Yang","year":"2020","journal-title":"Reprod. Biomed. Online"},{"key":"10.1016\/j.critrevonc.2025.104778_bib88","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.587051","article-title":"Improving reporting of clinical studies using the POSEIDON criteria: POSORT guidelines","volume":"12","author":"Esteves","year":"2021","journal-title":"Front Endocrinol. (Lausanne)"},{"key":"10.1016\/j.critrevonc.2025.104778_bib89","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1007\/s10815-020-01918-z","article-title":"Intrauterine insemination cycles: prediction of success and thresholds for poor prognosis and futile care","volume":"37","author":"Ainsworth","year":"2020","journal-title":"J. Assist Reprod. Genet"},{"key":"10.1016\/j.critrevonc.2025.104778_bib90","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1016\/j.fertnstert.2014.03.012","article-title":"A randomized clinical trial to determine optimal infertility treatment in older couples: the forty and over treatment trial (FORT-T)","volume":"101","author":"Goldman","year":"2014","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.critrevonc.2025.104778_bib91","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1056\/NEJM200007063430101","article-title":"Reducing the risk of high-order multiple pregnancy after ovarian stimulation with gonadotropins","volume":"343","author":"Gleicher","year":"2000","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.critrevonc.2025.104778_bib92","doi-asserted-by":"crossref","first-page":"a716","DOI":"10.1136\/bmj.a716","article-title":"Clomifene citrate or unstimulated intrauterine insemination compared with expectant management for unexplained infertility: pragmatic randomised controlled trial","volume":"337","author":"Bhattacharya","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.critrevonc.2025.104778_bib93","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1200\/JCO.2014.59.3723","article-title":"Fertility preservation success subsequent to concurrent aromatase inhibitor treatment and ovarian stimulation in women with breast cancer","volume":"33","author":"Oktay","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2025.104778_bib94","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1177\/1933719117728800","article-title":"Ovarian stimulation in patients with cancer: impact of letrozole and BRCA mutations on fertility preservation cycle outcomes","volume":"25","author":"Turan","year":"2018","journal-title":"Reprod. Sci."},{"key":"10.1016\/j.critrevonc.2025.104778_bib95","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.fertnstert.2004.01.006","article-title":"Aromatase inhibitors and teratogenesis","volume":"81","author":"Tiboni","year":"2004","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.critrevonc.2025.104778_bib96","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/j.fertnstert.2006.03.014","article-title":"Congenital malformations among 911 newborns conceived after infertility treatment with letrozole or clomiphene citrate","volume":"85","author":"Tulandi","year":"2006","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.critrevonc.2025.104778_bib97","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ejca.2022.07.017","article-title":"Efficacy and safety of controlled ovarian hyperstimulation with or without letrozole for fertility preservation in breast cancer patients: a multicenter retrospective study","volume":"174","author":"Goldrat","year":"2022","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.critrevonc.2025.104778_bib98","doi-asserted-by":"crossref","first-page":"361","DOI":"10.3389\/fendo.2018.00361","article-title":"The effect of dose adjustments in a subsequent cycle of women with suboptimal response following conventional ovarian stimulation","volume":"9","author":"Drakopoulos","year":"2018","journal-title":"Front Endocrinol. (Lausanne)"},{"key":"10.1016\/j.critrevonc.2025.104778_bib99","doi-asserted-by":"crossref","first-page":"387","DOI":"10.3389\/fendo.2019.00387","article-title":"Management of women with an unexpected low ovarian response to gonadotropin","volume":"10","author":"Conforti","year":"2019","journal-title":"Front Endocrinol. (Lausanne)"},{"key":"10.1016\/j.critrevonc.2025.104778_bib100","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12958-019-0460-4","article-title":"The role of recombinant LH in women with hypo-response to controlled ovarian stimulation: a systematic review and meta-analysis","volume":"17","author":"Conforti","year":"2019","journal-title":"Reprod. Biol. Endocrinol."},{"key":"10.1016\/j.critrevonc.2025.104778_bib101","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.fertnstert.2018.01.003","article-title":"International collaborative group for the study of r-hLH (iCOS-LH), recombinant luteinizing hormone supplementation in assisted reproductive technology: a systematic review","volume":"109","author":"Alviggi","year":"2018","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.critrevonc.2025.104778_bib102","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1093\/humrep\/dey217","article-title":"Luteal phase anovulatory follicles result in the production of competent oocytes: intra-patient paired case-control study comparing follicular versus luteal phase stimulations in the same ovarian cycle","volume":"33","author":"Cimadomo","year":"2018","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.critrevonc.2025.104778_bib103","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3389\/fendo.2018.00317","article-title":"Double stimulation in the same ovarian cycle (DuoStim) to maximize the number of oocytes retrieved from poor prognosis patients: a multicenter experience and SWOT analysis","volume":"9","author":"Vaiarelli","year":"2018","journal-title":"Front Endocrinol. (Lausanne)"},{"key":"10.1016\/j.critrevonc.2025.104778_bib104","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1080\/03009734.2020.1734694","article-title":"DuoStim - a reproducible strategy to obtain more oocytes and competent embryos in a short time-frame aimed at fertility preservation and IVF purposes. A systematic review","volume":"125","author":"Vaiarelli","year":"2020","journal-title":"Ups. J. Med Sci."},{"key":"10.1016\/j.critrevonc.2025.104778_bib105","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.fertnstert.2016.06.017","article-title":"Elective single embryo transfer in women less than age 38 years reduces multiple birth rates, but not live birth rates, in United States fertility clinics","volume":"106","author":"Mancuso","year":"2016","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.critrevonc.2025.104778_bib106","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.fertnstert.2021.06.050","article-title":"Electronic address: ASRM@asrm.org, guidance on the limits to the number of embryos to transfer: a committee opinion","volume":"116","author":"Practice Committee of the American Society for Reproductive Medicine and the Practice Committee for the Society for Assisted Reproductive Technologies","year":"2021","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.critrevonc.2025.104778_bib107","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/ijgo.12375","article-title":"Meta-analysis of associations between maternal breast cancer and the risk of adverse delivery outcomes","volume":"140","author":"Sun","year":"2018","journal-title":"Int J. Gynaecol. Obstet."},{"key":"10.1016\/j.critrevonc.2025.104778_bib108","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s10549-016-3989-3","article-title":"The prognosis of women diagnosed with breast cancer before, during and after pregnancy: a meta-analysis","volume":"160","author":"Hartman","year":"2016","journal-title":"Breast Cancer Res Treat."},{"key":"10.1016\/j.critrevonc.2025.104778_bib109","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/ijgo.12375","article-title":"Meta-analysis of associations between maternal breast cancer and the risk of adverse delivery outcomes","volume":"140","author":"Sun","year":"2018","journal-title":"Int J. Gynaecol. Obstet."},{"key":"10.1016\/j.critrevonc.2025.104778_bib110","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s10549-019-05244-6","article-title":"Childbirth in young Korean women with previously treated breast cancer: the SMARTSHIP study","volume":"176","author":"Lee","year":"2019","journal-title":"Breast Cancer Res Treat."},{"key":"10.1016\/j.critrevonc.2025.104778_bib111","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s10549-019-05154-7","article-title":"Tamoxifen and pregnancy: an absolute contraindication?","volume":"175","author":"Schuurman","year":"2019","journal-title":"Breast Cancer Res Treat."},{"key":"10.1016\/j.critrevonc.2025.104778_bib112","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/cncr.31784","article-title":"Pregnancies during and after trastuzumab and\/or lapatinib in patients with human epidermal growth factor receptor 2-positive early breast cancer: analysis from the NeoALTTO (BIG 1-06) and ALTTO (BIG 2-06) trials","volume":"125","author":"Lambertini","year":"2019","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2025.104778_bib113","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ejogrb.2021.10.004","article-title":"Single blastocyst stage versus single cleavage stage embryo transfer following fresh transfer: a systematic review and meta-analysis","volume":"267","author":"Li","year":"2021","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.critrevonc.2025.104778_bib114","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.fertnstert.2018.05.012","article-title":"Cumulative live birth rate in freeze-all cycles is comparable to that of a conventional embryo transfer policy at the cleavage stage but superior at the blastocyst stage","volume":"110","author":"Zac\u00e0","year":"2018","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.critrevonc.2025.104778_bib115","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.fertnstert.2018.01.002","article-title":"Electronic address: ASRM@asrm.org, practice committees of the American society for reproductive Medicine and the society for assisted reproductive technology, the use of preimplantation genetic testing for aneuploidy (PGT-A): a committee opinion","volume":"109","author":"Practice Committees of the American Society for Reproductive Medicine and the Society for Assisted Reproductive Technology","year":"2018","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.critrevonc.2025.104778_bib116","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.fertnstert.2013.02.056","article-title":"In vitro fertilization with single euploid blastocyst transfer: a randomized controlled trial","volume":"100","author":"Forman","year":"2013","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.critrevonc.2025.104778_bib117","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.rbmo.2020.10.020","article-title":"Preimplantation genetic testing for aneuploidy: a Canadian fertility and andrology society guideline","volume":"42","author":"Chan","year":"2021","journal-title":"Reprod. Biomed. Online"},{"key":"10.1016\/j.critrevonc.2025.104778_bib118","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/j.fertnstert.2021.01.045","article-title":"Electronic address: ASRM@asrm.org, guidance regarding gamete and embryo donation","volume":"115","author":"Practice Committee of the American Society for Reproductive Medicine and the Practice Committee for the Society for Assisted Reproductive Technology","year":"2021","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.critrevonc.2025.104778_bib119","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.rbmo.2021.09.025","article-title":"A decision tree analysis applied to women aged 43-45: who should be referred for ovum donation?","volume":"44","author":"Bercovich","year":"2022","journal-title":"Reprod. Biomed. Online"},{"key":"10.1016\/j.critrevonc.2025.104778_bib120","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.jogc.2016.12.004","article-title":"No. 346-Advanced reproductive age and fertility","volume":"39","author":"Liu","year":"2017","journal-title":"J. Obstet. Gynaecol. Can."},{"key":"10.1016\/j.critrevonc.2025.104778_bib121","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.rbmo.2009.04.002","article-title":"Assisted reproduction in women over 40 years of age: how old is too old?","volume":"19","author":"Hourvitz","year":"2009","journal-title":"Reprod. Biomed. Online"},{"key":"10.1016\/j.critrevonc.2025.104778_bib122","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/j.fertnstert.2009.09.044","article-title":"Analysis of 2,386 consecutive cycles of in vitro fertilization or intracytoplasmic sperm injection using autologous oocytes in women aged 40 years and above","volume":"94","author":"Serour","year":"2010","journal-title":"Fertil. Steril."}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842825001660?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842825001660?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T20:48:23Z","timestamp":1756154903000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842825001660"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":122,"alternative-id":["S1040842825001660"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2025.104778","relation":{},"ISSN":["1040-8428"],"issn-type":[{"type":"print","value":"1040-8428"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of ovarian reserve in breast cancer patients seeking pregnancies (MORE BREAKS): A Delphi consensus","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2025.104778","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104778"}}